Loading provider…
Loading provider…
Neurology Physician in Gilbert, AZ
NPI: 1154642205Primary Practice Location
Gilbert Neurology Partners PLLC
7400 S Power Rd, Gilbert, AZ
Primary Employer
Gilbert Neurology Partners PLLC
gilbertneurology.com
HQ Phone
Get MD Brian's Phone Numberphone_androidMobile
Get MD Brian's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIN State Medical License
AZ State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 605 | 932 |
| 2 | 99204New patient office or other outpatient visit, 45-59 minutes | 202 | 202 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 179 | 236 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 61 | 64 |
| 5 | 99205New patient office or other outpatient visit, typically 60 minutes | 42 | 42 |
Fanconi anemia D2 protein is an apoptotic target mediated by caspases.
Authors: Laura Haneline
Journal: J Cell Biochem
Biochemical characterization of metnase's endonuclease activity and its role in NHEJ repair.
Authors: Brian Beck, Sung-sook Lee, Elizabeth Williamson, Robert Hromas, Suk-hee Lee
Publication Date: 2011-04-16
Lead Sponsor: Cassava Sciences, Inc.
Collaborators: National Institute on Aging (NIA)
Intervention / Treatment: DRUG: Placebo, DRUG: Simufilam 100 mg oral tablet
Lead Sponsor: Tetra Discovery Partners
Intervention / Treatment: DRUG: Placebo, DRUG: BPN14770
Lead Sponsor: Cassava Sciences, Inc.
Collaborators: National Institute on Aging (NIA)
Intervention / Treatment: DRUG: Placebo oral tablet, DRUG: Simufilam 100 mg tablet, DRUG: Simufilam 50 mg oral tablet